title: Volume-selective proton MR spectroscopy for in-vitro quantification of anticonvulsants.
abstract: Administration of anticonvulsant drugs is clinically monitored by checking seizure frequency and by determining the serum concentration of the drug. In a few reports, drug concentrations in brain parenchyma have been determined using ex vivo techniques. Little is known about the in vivo concentration in the brain parenchyma. Our goals were to characterise the NMR spectra of the anticonvulsants at therapeutic concentrations, to determine the minimum detectable concentrations, and to quantify the drugs noninvasively. Volume-selective 1H-MR spectroscopy (MRS) was performed under standard clinical conditions using a single-voxel STEAM (stimulated-echo acquisition mode) sequence at 1.5 T. Spectra of the anticonvulsants carbamazepine, phenobarbital, phenytoin and valproate were acquired in vitro in hydrous solutions at increasing dilution. Phenytoin, phenobarbital and valproate were detectable below maximum therapeutic serum concentrations. Within therapeutic ranges, there was good agreement between concentrations determined by 1H-MRS and those by standard fluorescence polarisation immunoassay. Due to the absence of signals of brain metabolites, the aromatic protons of phenobarbital, phenytoin and carbamazepine, with resonance lines around 7.4 ppm, allow the drugs to be detected. Valproate, with two resonances around 1.2 ppm, should be differentiable from potential brain metabolites using nonlinear analysis of the brain spectrum. Volume-selective 1H-MRS is therefore expected to be able to monitor anticonvulsant therapy in vivo.
authors: Institute of Medical Informatics, Biometry and Epidemiology, University Hospital Benjamin Franklin, Free University Berlin, Germany. braun@ukbf.fu-berlin.de
authors: J
authors: J
authors: Braun
authors: S
authors: S
authors: Seyfert
authors: J
authors: J
authors: Bernarding
authors: A
authors: A
authors: Schilling
authors: P
authors: P
authors: Marx
authors: T
authors: T
authors: Tolxdorff
mesh_terms: D000927:Anticonvulsants / Q000032:analysis* / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D007118:Immunoassay; D066298:In Vitro Techniques; D009682:Magnetic Resonance Spectroscopy / Q000379:methods*; D011522:Protons; D015203:Reproducibility of Results; D012640:Seizures; D012680:Sensitivity and Specificity
chemical_list: D000927:Anticonvulsants; D011522:Protons